Table 1 |
||||
| Baseline characteristics, clinical presentation, and outcome of diabetic patients with controlled or uncontrolled glycemia | ||||
| Controlled glycemia (n = 19) | Uncontrolled glycemia (n = 83) | p value | p value, (adjusted age) | |
| Male | 12 (63.2) | 59 (71.1) | 0.498 | 0.952 |
| Age in years | 70.6 ± 9.6 | 62.8 ± 14.9 | 0.017 | |
| Underlying diseases | ||||
| Malignancy | 1 (5.6) | 10 (12.7) | 0.683 | 0.367 |
| Alcoholism | 1 (5.3) | 4 (4.8) | 1.000 | 0.655 |
| Chronic kidney disease | 1 (5.6) | 8 (10.3) | 1.000 | 0.311 |
| Liver cirrhosis | 0 (0) | 2 (2.4) | 1.000 | 0.494 |
| Congestive heart failure | 0 (0) | 2 (2.4) | 1.000 | 0.392 |
| Chronic lung disease | 0 (0) | 1 (1.2) | 1.000 | 0.549 |
| Newly diagnosed diabetes | 4 (21.1) | 21 (25.3) | 1.000 | 0.995 |
| Origin | ||||
| Cryptogenic | 15 (78.9) | 77 (92.8) | 0.087 | 0.090 |
| Biliary tract origin | 1 (5.3) | 5 (6.0) | 1.000 | 0.785 |
| Abscess locations | ||||
| Right lobe | 11 (57.9) | 44 (53.0) | 0.791 | 0.407 |
| Left lobe | 5 (26.3) | 19 (22.9) | ||
| Both lobes | 3 (15.8) | 20 (24.1) | ||
| Abscess size | ||||
| < 5 cm | 9 (47.4) | 36 (43.4) | 1.000 | 0.707 |
| 5 ~ 10 cm | 9 (47.4) | 39 (47.0) | ||
| >; 10 cm | 1 (5.3) | 8 (9.6) | ||
| Gas forming | 0 (0) | 12 (14.5) | 0.116 | 0.126 |
| Multiple abscesses | 8 (42.1) | 29 (34.9) | 0.558 | 0.791 |
| Initial laboratory value | ||||
| Leukocyte count, × 103/μL | 12.4 ± 3.8 | 13.5 ± 6.0 | 0.165 | 0.417 |
| Platelet, × 103/μL | 195 ± 87 | 229 ± 121 | 0.145 | 0.442 |
| C-reactive protein, mg/dL | 18.8 ± 9.2 | 20.0 ± 9.8 | 0.487 | 0.779 |
| Glucose, mg/dL | 193 ± 76 | 318 ± 168 | 0.007 | 0.004 |
| Treatment | ||||
| Antibiotics + drainage | 16 (84.2) | 69 (83.1) | 1.000 | 0.894 |
| Antibiotics + operation | 1 (5.3) | 3 (3.6) | 0.568 | 0.525 |
| Antibiotics only | 2 (10.5) | 11 (13.4) | 1.000 | 0.557 |
| Metastatic infections | 0 (0) | 12 (14.5) | 0.116 | 0.077 |
| Outcome | ||||
| Hospitalization days | 26.2 ± 12.1 | 28.1 ± 19.0 | 0.692 | 0.428 |
| Intensive care unit admission | 2 (10.5) | 12 (14.5) | 1.000 | 0.849 |
| Mortality | 0 (0) | 3 (3.6) | 1.000 | 0.359 |
Data are presented as mean ± SD or frequency with percentage (%).
Lin et al. BMC Infectious Diseases 2013 13:56 doi:10.1186/1471-2334-13-56
